CVE-2025-65080Type confusion vulnerability in Postscript interpreter
Updated under an hour ago ()
Does this affect you?
It affects Lexmark MXTCT, MSNGM, MSTGM, MXNGM, MXTGM, CSNGV, CSTGV, CXTGV, MSNGW, MSTGW, MXTGW, CSTLS, CXTLS, MXTLS, CSTMM, CXTMM, CSTPC, CXTPC, MXTPM, MSNSN, MSTSN, MXTSN, CSNZJ, CSTZJ, CXNZJ, CXTZJ and 1 other product. Add what you run to find out whether that includes you.
No exploitation reported and no EPSS estimate yet.
A type confusion vulnerability has been identified in the Postscript interpreter in various Lexmark devices. This vulnerability can be leveraged by an attacker to execute arbitrary code as an unprivileged user.
- CVSS
- 6.9 MEDIUM (v4.0, CNA)CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N
- Weakness (CWE)
- CWE-843
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- Not loaded for this CVE
- Assigned by
- Lexmark
- NVD analysis
- Deferred
- Record last updated
- Feb 26, 2026
- First seen by InfoSec Signals
- Oct 9, 2026
Affected products
Lexmark MXTCT, MSNGM, MSTGM, MXNGM, MXTGM, CSNGV, CSTGV, CXTGV, MSNGW, MSTGW, MXTGW, CSTLS, CXTLS, MXTLS, CSTMM, CXTMM, CSTPC, CXTPC, MXTPM, MSNSN, MSTSN, MXTSN, CSNZJ, CSTZJ, CXNZJ, CXTZJ lexmark:mxtct_msngm_mstgm_mxngm_mxtgm_csngv_cstgv_cxtgv_msngw_mstgw_mxtgw_cstls_cxtls_mxtls_cstmm_cxtmm_cstpc_cxtpc_mxtpm_msnsn_mstsn_mxtsn_csnzj_cstzj_cxnzj_cxtzj (from the name) | before 250.210 | CNA record |
Lexmark CSTAT, CXTAT, MSLBD, MXLBD, CSLBL, CXLBL, CSLBN, CXLBN, CSTMH, CXTMH, CSTPP, CXTPP, MSLSG, MXLSG lexmark:cstat_cxtat_mslbd_mxlbd_cslbl_cxlbl_cslbn_cxlbn_cstmh_cxtmh_cstpp_cxtpp_mslsg_mxlsg (from the name) | before 230.506 | CNA record |
References
- https://www.lexmark.com/en_us/solutions/security/lexmark-security-advisories.html
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.